Healthcare -
Biotechnology - NASDAQ - US
$ 1.235
0.406 %
$ 258 M
Market Cap
-1.74
P/E
SGMO - STOCK-BASED COMPENSATION
Stock-based Compensation SGMO - Sangamo Therapeutics, Inc.
27.4 M
LAST VALUE
-8.88%
2 YEAR CAGR
13.27%
5 YEAR CAGR
16.11%
10 YEAR CAGR